(May 18, 2016, 1:47 PM EDT) -- TAHLEQUAH, Okla. — Drugmakers accused by the Cherokee Nation of negligently selling the diabetes drug Actos to tribal members who developed bladder cancer due to the drug urged the tribe’s supreme court on May 3 to reverse a tribal court finding that it has jurisdiction over the companies at issue (Takeda Pharmaceuticals USA, Inc., et al. v. The Cherokee Nation, et al., No. SC-16-02, Cherokee Sup.).

(Appellants’ brief available. Document #96-160513-058B.)

Jurisdiction

The Cherokee Nation sued Takeda, several Takeda affiliates and Eli Lilly & Co. in...